GB Patent

GB2465099A — A capsule with low tackiness

Assigned to Optinose AS · Expires 2010-05-12 · 16y expired

What this patent protects

A capsule 7 for containing a powdered substance, and use thereof, which exhibits insufficient tackiness, and preferably no surface tackiness, in the presence of moisture such as not to adhere to an inner surface of a capsule chamber 5 which contains the capsule 7 during emptying …

USPTO Abstract

A capsule 7 for containing a powdered substance, and use thereof, which exhibits insufficient tackiness, and preferably no surface tackiness, in the presence of moisture such as not to adhere to an inner surface of a capsule chamber 5 which contains the capsule 7 during emptying of the capsule 7. The capsule 7 may be formed substantially of one of hydroxypropyl methylcellulose (HPMC), hydroxypropylcellulose, methylcellulose, ethylcellulose, and carboxymethylcellulose.

Drugs covered by this patent

Patent Metadata

Patent number
GB2465099A
Jurisdiction
GB
Classification
—
Expires
2010-05-12
Drug substance claim
No
Drug product claim
No
Assignee
Optinose AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.